Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             373 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 2005
 15 S2 p. S301-S307
7 p.
 artikel
2 Keyword index 2005
 15 S2 p. S309-S312
4 p.
 artikel
3 L.2 Current status of genetics of bipolar disorder Craddock, N.
 2005
 15 S2 p. S87-
1 p.
 artikel
4 L.1 Mechanism of individual responses to emotional stress and tranquilizers Seredenin, S.B.
 2005
 15 S2 p. S87-
1 p.
 artikel
5 P.3.040 A comparison of clinical efficacy andsafety of proproten and diazepam for the treatment of anxiety disorders Dugina, J.L.
 2005
 15 S2 p. S161-S162
2 p.
 artikel
6 P.5.105 Action of β-amyloid peptide and TNF-αon sphingomyelin cycle signaling system and lipid peroxide oxidation in rat brain sections Bugrova, A.E.
 2005
 15 S2 p. S260-S261
2 p.
 artikel
7 P.6.023 Action of chronic caffeine consumption on individual sensitivity to morphine, ethanol and nicotine Rusakova, I.V.
 2005
 15 S2 p. S277-
1 p.
 artikel
8 P.5.078 Acute focal cerebral ischemia andcoenzyme Q Povarova, O.V.
 2005
 15 S2 p. S244-4245
NaN p.
 artikel
9 P.6.036 A double-blind, placebo controlled trial of naltrexone and fluoxetine for heroin addiction treatment Krupitsky, E.
 2005
 15 S2 p. S284-
1 p.
 artikel
10 P.5.080 Afobazole protects neurons against oxidative stress and glutamate toxicity in vitro Zenina, T.A.
 2005
 15 S2 p. S246-
1 p.
 artikel
11 P.3.055 Alprazolam: Clinical dynamics in neurotic disorders Kupriyanova, I.E.
 2005
 15 S2 p. S170-
1 p.
 artikel
12 P.6.013 2-Amino-adamantane derivativeLadasten enhances ex vivo dopamine synthesis and release in rat striata Lapa, G.B.
 2005
 15 S2 p. S271-S272
2 p.
 artikel
13 P.2.003 Amisulpride in the treatment of patients with somatoform disorders Văideanu, C.
 2005
 15 S2 p. S130-
1 p.
 artikel
14 P.5.076 Analysis of cerebrovascular andneuroprotective effects of afobazole Silkina, I.V.
 2005
 15 S2 p. S243-A244
nvt p.
 artikel
15 P.2.007 Analysis of the action of antipsychotics in a 5-factor model of schizophrenia Kuzavkova, M.V.
 2005
 15 S2 p. S131-S132
2 p.
 artikel
16 P.5.014 A novel method for memory dynamics evaluation can become the best test for early pre-diagnostics of Alzheimer's disease Sapronov, N.S.
 2005
 15 S2 p. S207-S208
2 p.
 artikel
17 P.5.017 Antiamnesic action of zinc salts Zurdinov, A.Z.
 2005
 15 S2 p. S209-S210
2 p.
 artikel
18 P.5.060 Antiamnestic mechanisms of CK2 modulators in old rats Reichardt, B.A.
 2005
 15 S2 p. S234-S235
2 p.
 artikel
19 P.4.010 Antidepressant therapy effects infibromyalgia patients Atarowska, M.
 2005
 15 S2 p. S177-
1 p.
 artikel
20 P.6.010 Antioxidants in protecting erythrocyte proteins against damage under influence of acetaldehyde Prokopieva, V.D.
 2005
 15 S2 p. S269-S270
2 p.
 artikel
21 P.6.30 Antirelapsing risperidone monotherapy of drug addiction Nosatovsky, I.A.
 2005
 15 S2 p. S281-
1 p.
 artikel
22 P.3.022 Antistressory effect of mexidol in inbredC57BL/6 and BALB/C mice Sariev, A.K.
 2005
 15 S2 p. S152-
1 p.
 artikel
23 P.1.004 Anxiety affects the developmentof experimental pain—depressive syndromes in two rat models Krupina, N.A.
 2005
 15 S2 p. S105-
1 p.
 artikel
24 P.3.030 Anxiety and depressive disorders in late postoperative period of coronary artery bypass graft surgery (CABG) Samuchia, M.A.
 2005
 15 S2 p. S156-S157
2 p.
 artikel
25 P.3.024 Anxiolytic afobazole defends the genome from adverse action of chemical mutagens Zhanataev, A.K.
 2005
 15 S2 p. S153-
1 p.
 artikel
26 P.3.009 Anxiolytic properties of afobazole incomparison with diazepam Yarkova, M.A.
 2005
 15 S2 p. S145-
1 p.
 artikel
27 P.3.013 Anxiolytic properties of 5-HT3-receptorantagonists Chernikov, M.V.
 2005
 15 S2 p. S147-S148
2 p.
 artikel
28 P.4.013 Application of new supplementwith antioxidant properties at aging (experimental data) Spasov, A.A.
 2005
 15 S2 p. S179-
1 p.
 artikel
29 P.6.042 Aprotinin as a new drug for treatment of opiate withdrawal syndrome Sudakov, S.K.
 2005
 15 S2 p. S288-
1 p.
 artikel
30 P.6.027 Association study of tyrosine hydroxylaseand dopamine receptor type 2 gene polymorphisms and heroin addiction with a family history of alcoholism Kibitov, A.O.
 2005
 15 S2 p. S279-
1 p.
 artikel
31 P.4.034 Autoimmune responses to proteins HLDF and S100b as pathogenic factors and molecular markers of cerebrovascular diseases Elistratova, E.I.
 2005
 15 S2 p. S191-
1 p.
 artikel
32 P.5.089 Autoimmune responses to proteins HLDF and S100b as pathogenic factors and molecular markers of cerebrovascular diseases Elistratova, E.I.
 2005
 15 S2 p. S251-
1 p.
 artikel
33 P.4.043 Autonomic and behavioral effects ofintracerebroventricular injected CRF Gourine, V.N.
 2005
 15 S2 p. S196-
1 p.
 artikel
34 P.5.059 Behavioral consequences of combined manganese and piracetam administration Petrov, A.N.
 2005
 15 S2 p. S234-
1 p.
 artikel
35 P.6.065 Behavioral differences between alcohol-dependent mice forcibly treated or not treated with water Akhundov, R.A.
 2005
 15 S2 p. S299-
1 p.
 artikel
36 P.6.009 Behavioural effects of cholecystokinin-4 dipeptide retro-analog in naive and morphine-dependent rats Konstantinopolsky, M.A.
 2005
 15 S2 p. S269-
1 p.
 artikel
37 P.5.011 Binding of regulatory neuropeptide [3H]-Semax (MEHFPGP), labeled in terminal Pro, to plasma membranes of the rat forebrain V'unova, T.V.
 2005
 15 S2 p. S206-
1 p.
 artikel
38 P.3.021 Biologically active conformation of cholecystokinin-4 retropeptide analogues with anxiolytic activity Kir'yanova, E.P.
 2005
 15 S2 p. S152-
1 p.
 artikel
39 P.6.004 Blood lymphocyte adenylate cyclase complex in rats with different susceptibility to opiate dependence Tomilin, V.A.
 2005
 15 S2 p. S266-
1 p.
 artikel
40 P.5.048 Botulinum toxin in focal dystoniapatients Antipenko, E.A.
 2005
 15 S2 p. S227-S228
2 p.
 artikel
41 P.5.032 Calcium homeostasis and signal transduction alternations in rat brain cortex under the influence of hypokinesia and GABA Melkonyan, K.V.
 2005
 15 S2 p. S218-S219
2 p.
 artikel
42 P.6.06C Alcohol modulates the properties of benzodiazepine receptors and neuroendocrine functions Shushpanova, T.V.
 2005
 15 S2 p. S297-
1 p.
 artikel
43 P.5.110 Can ampakines reverse cognitivedeficits in healthy adults? Mishory, A.
 2005
 15 S2 p. S263-
1 p.
 artikel
44 P.3.006 Can diazepam improve reduced socialand sexual behavioral reactions in anxious male mice? Amikishieva, A.V.
 2005
 15 S2 p. S143-S144
2 p.
 artikel
45 P.5.028 CB1 cannabinoid receptor-mediatedprotection against excitotoxic damage of hippocampal neurons in vitro: Histological and ultrastructural analysis Khaspekov, L.
 2005
 15 S2 p. S216-
1 p.
 artikel
46 P.1.011 Central action of 9-[2-(4isopropylphenoxy)ethyl] adenine on brain neurotransmission Ananyeva, O.Yu.
 2005
 15 S2 p. S108-S109
2 p.
 artikel
47 P.6.021 Cerebrolysin in the treatment of cerebralatrophic changes in alcoholic patients Tuchkova, M.Ye.
 2005
 15 S2 p. S276-
1 p.
 artikel
48 P.5.102 Change of cerebral acid-base balance with chronic brain ischemic disease in response to vinpotropil therapy Fokin, V.F.
 2005
 15 S2 p. S259-
1 p.
 artikel
49 P.4.022 Changes in gene expression profiles in rat brain induced by Ladasten Yamidanov, R.S.
 2005
 15 S2 p. S184-S185
2 p.
 artikel
50 P.5.043 Changes in lymphocytes functionalactivity as an indication of the epileptic preconvulsive status Lioubimov, I.A.
 2005
 15 S2 p. S225-
1 p.
 artikel
51 P.5.031 Changes of GABA content in different rat brain regions under the conditions of experimental hypokinesia Karapetyan, V.H.
 2005
 15 S2 p. S218-
1 p.
 artikel
52 P.4.008 Cholinergic modulation of sexual behaviorafter stress: Behavioral correlations Bairamov, A.A.
 2005
 15 S2 p. S175-S176
2 p.
 artikel
53 P.4.009 Cholinergic modulation ofsexual behavior after stress: Neurochemical correlations Bairamov, A.A.
 2005
 15 S2 p. S176-S177
2 p.
 artikel
54 P.6.012 Chronic ethanol administration and hippocampal neurogenesis Jaako-Movits, K.
 2005
 15 S2 p. S271-
1 p.
 artikel
55 P.1.041 Chronobiological effect of propranolol in the treatment of depression Andruskevicius, S.
 2005
 15 S2 p. S125-S126
2 p.
 artikel
56 P.1.016 Chronopharmacological resemblance of antidepressant and anxiolytic drugs Bayer, E.V.
 2005
 15 S2 p. S112-
1 p.
 artikel
57 P.4.045 Chronopharmacology of drugsimproving cognitive brain functions Arushanian, E.B.
 2005
 15 S2 p. S197-
1 p.
 artikel
58 P.2.005 Circulatory levels ofcatecholamines and serotonin in neuroleptic malignant syndrome Malin, D.
 2005
 15 S2 p. S131-
1 p.
 artikel
59 P.6.024 Citalopram in the treatment of alcohol dependence Nebarakova, T.P.
 2005
 15 S2 p. S277-S278
2 p.
 artikel
60 P.6.063 Clinical and biological effectiveness of anar therapy in opiate addicts Bokhan, N.A.
 2005
 15 S2 p. S298-
1 p.
 artikel
61 P.6.035 Clinical and experimental study of the effect of antaxone on dopamine neurotransmission in opiate dependence Veretinskaya, A.G.
 2005
 15 S2 p. S283-S284
2 p.
 artikel
62 P.5.046 Clinical and immunological study ofpatients with psychogenic asthenia: The way for optimization of therapy Moroz, I.N.
 2005
 15 S2 p. S227-
1 p.
 artikel
63 P.3.041 Clinical and neurophysiologicalefficacy of neurofeedback in the combined therapy of anxiety disorders resistant to psychopharmacotherapy Biriukova, E.N.
 2005
 15 S2 p. S162-S163
2 p.
 artikel
64 P.1.023 Clinical and psychological predictorsof pharmacotherapy refusals in patients with non-psychotic depressions Borodin, V.I.
 2005
 15 S2 p. S115-S116
2 p.
 artikel
65 P.1.044 Clinical efficacy of vasopressin in thetreatment of poststroke depression Tsikunov, S.G.
 2005
 15 S2 p. S127-
1 p.
 artikel
66 P.5.041 Clinical encephalographic analysis of the use of nooclerin with patients suffering from epilepsy Rogacheva, T.A.
 2005
 15 S2 p. S224-
1 p.
 artikel
67 P.5.037 Clinical pharmaco-EEG characteristic ofthe novel nootropic drug noopept Davidova, I.A.
 2005
 15 S2 p. S221-S222
2 p.
 artikel
68 P.5.038 Clinical pharmacological study of thenovel peptide nootropic drug noopept Teleshova, E.S.
 2005
 15 S2 p. S222-
1 p.
 artikel
69 P.5.012 Coenzyme Q and α-tocopherol in rat brain during aging and after long-term coenzyme Q and α-tocopherol containing nutrient supplementation Kalenikova, E.I.
 2005
 15 S2 p. S206-S207
2 p.
 artikel
70 P.1.006 Combination of bemithyl and pyrazidolas an antiasthenic tool in delayed posttraumatic period Zarubina, I.P.
 2005
 15 S2 p. S106-
1 p.
 artikel
71 P.2.006 Combined olanzapine-ECT therapy forresistant schizophrenia Oleneva, E.
 2005
 15 S2 p. S131-
1 p.
 artikel
72 P.6.033 Combined Prodetoxon (naltrexone-long)and Vitagam-Rulin treatment of opiate addicted patients Mikhaleva, L.D.
 2005
 15 S2 p. S282-S283
2 p.
 artikel
73 P.2.008 Comparative clinical efficacy of atypicalantipsychotics and haloperidol in treatment of acute schizophrenia relapses Eremin, A.N
 2005
 15 S2 p. S132-
1 p.
 artikel
74 P.4.019 Comparative description of transcutaneous conductivity of Silicic Glycerohydrohelium Bovakovskava, T.G.
 2005
 15 S2 p. S182-S183
2 p.
 artikel
75 P.6.025 Comparative efficiency of quetiapine fumarate in treatment of patients with alcohol dependence Gofman, A.G.
 2005
 15 S2 p. S278-
1 p.
 artikel
76 P.1.035 Comparative pharmacoeconomic analysis of effectiveness of the combined therapy provided to the children with depressive behavioral disorder arising on the background of residual-organic brain lesion Redkin, Y.V.
 2005
 15 S2 p. S122-
1 p.
 artikel
77 P.5.085 Comparative study of antimigraineactivity of tropoxin and other antimigraine medicaments Ganshina, T.S.
 2005
 15 S2 p. S248-S249
2 p.
 artikel
78 P.4.014 Comparative study of Ladasten, Sydnocarb and their combination effects Levina, M.N.
 2005
 15 S2 p. S179-S180
2 p.
 artikel
79 P.1.005 Comparative study of pharmacological activity of antidepressants fluoxetine and tianeptine Meletova, O.K.
 2005
 15 S2 p. S105-S106
2 p.
 artikel
80 P.5.002 Comparative study of psychotropicactivity of pyridine derivatives of γ-aminobutyric and glutamic acids Voronkov, A.V.
 2005
 15 S2 p. S200-S201
2 p.
 artikel
81 P.4.015 Comparative study of the impact of combinedSydnocarb-Ladasten on physical work ability of laboratory animals Levina, M.N.
 2005
 15 S2 p. S180-
1 p.
 artikel
82 P.1.028 Comparison of anxiety anddepression levels in patients with central nervous system disorders and patients with neuromuscular pathology Grigorieva, V.N.
 2005
 15 S2 p. S118-
1 p.
 artikel
83 P.2.002 Conformationally constrained analogues of antipsychotic dipeptide N-caproyl-L-prolyl-L-tyrosine methyl ester Ignashin, A.N.
 2005
 15 S2 p. S129-
1 p.
 artikel
84 P.5.086 Correction of motor disturbances inrats with perinatal hypoxic-ischaemic affection of the CNS by transplantation of embryonal nervous cell preparation into the hippocamp CAI zone Chekhonin, V.P.
 2005
 15 S2 p. S249-S250
2 p.
 artikel
85 P.2.015 Correlation between antipyrine metabolism and neuroleptic load in shizophrenic patients Ziganshina, L.E.
 2005
 15 S2 p. S136-
1 p.
 artikel
86 P.6.037 Craving in heroine addicts maintainedon naltrexone Egorova, V.
 2005
 15 S2 p. S285-
1 p.
 artikel
87 P.5.090 Cytokine mechanisms of glutamate modulationof demyelinating process under experimental allergic encephalomyelitis Abdurasulova, I.N.
 2005
 15 S2 p. S252-
1 p.
 artikel
88 P.1.020 Degree of improvement in depressivepatients who have committed suicide attempts Voitcekh, V.F.
 2005
 15 S2 p. S114-
1 p.
 artikel
89 P.3.032 Dependence of Semax long-lasting effects on the time of its neonatal administration Sebentsova, E.A.
 2005
 15 S2 p. S157-S158
2 p.
 artikel
90 P.5.062 Design of nootropic dipeptides using the evolutional-genetic approach Morozova, A.A.
 2005
 15 S2 p. S235-S236
2 p.
 artikel
91 P.3.002 Discriminative stimulus effects of cycloprolyl-glycine Petlyanina, E.V.
 2005
 15 S2 p. S141-
1 p.
 artikel
92 P.3.001 Discriminative stimulus effects of mexidol in rats Kalinina, T.S.
 2005
 15 S2 p. S140-S141
2 p.
 artikel
93 P.6.041 Dopamine D2 receptor gene and drug abuse: Prevalence of combined A1/A2 Taql A and C/C Ncol genotypes in alcohol- and heroin-dependent patients Shamakina, I.Yu.
 2005
 15 S2 p. S287-
1 p.
 artikel
94 P.5.054 Dopaminergic regulation of cognitive functions under acute stress conditions in rats Bondarenko, N.A.
 2005
 15 S2 p. S231-
1 p.
 artikel
95 P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder Feighner, J.P.
 2005
 15 S2 p. S119-
1 p.
 artikel
96 P.5.094 Drug-based design of biologicallyactive dipeptides Gudasheva, T.
 2005
 15 S2 p. S254-
1 p.
 artikel
97 P.5.052 Early benefit of interferon β-1b inneuropsychiatric abnormalities in multiple sclerosis Sirbu, C.A.
 2005
 15 S2 p. S229-S230
2 p.
 artikel
98 P.4.048 Early complex developmental diagnosisand early intervention programme for children born with very low birth weight Gajewska, E.
 2005
 15 S2 p. S199-
1 p.
 artikel
99 P.3.017 Effect of afobazole on brain-derived neurotrophic factor protein in brain of inbred mice exposed to emotional stress Melkumyan, D.S.
 2005
 15 S2 p. S149-S150
2 p.
 artikel
100 P.5.047 Effect of anxiety and depression on the efficiency of treatment of torticollis patients Guzanova, E.V.
 2005
 15 S2 p. S227-
1 p.
 artikel
101 P.5.077 Effect of docosahexaenoic dopamine oncerebral circulation in rats after global reversible brain ischemia Khailov, N.A.
 2005
 15 S2 p. S244-
1 p.
 artikel
102 P.5.075 Effect of esafosfina on cerebral microcirculation in intact and ischemized rat brain Alexandrin, V.V.
 2005
 15 S2 p. S243-
1 p.
 artikel
103 P.5.097 Effect of lamictal on EEG paroxysmal activity of the female rat brain in different stages of the oestrous cycle Rider, F.K.
 2005
 15 S2 p. S256-S256
1 p.
 artikel
104 P.4.020 Effect of MgCl2·6H2O with vitamin B6 on the emotional status and magnesium content in brain structures of rats fed with magnesium-deficient diet Spasov, A.A.
 2005
 15 S2 p. S183-S184
2 p.
 artikel
105 P.2.021 Effects of atypical neurolepticquetiapine on blood indices, humoral immunity and body weight in patients with schizophrenia Lobachoyva, O.A.
 2005
 15 S2 p. S139-
1 p.
 artikel
106 P.5.055 Effects of dipeptide nootropic noopept on immunity parameters in stressed CBA, C57BL/6 and F1(CBA×C57BL/6) mice Shipaeva, E.V.
 2005
 15 S2 p. S231-S232
2 p.
 artikel
107 P.4.039 Effects of gabapentin on tactile allodynia induced by chronic constriction injury in rats Malyshkin, A.A.
 2005
 15 S2 p. S193-S194
2 p.
 artikel
108 P.6.003 Effects of galavit on the nitrergic system in rat brain regions during morphine withdrawal Peregud, D.I.
 2005
 15 S2 p. S265-
1 p.
 artikel
109 P.5.053 Effects of N-cholinergic drugs on behavior in the explorative cross-maze in mice: Comparison with cognitive enhancers Salimov, R.M.
 2005
 15 S2 p. S230-
1 p.
 artikel
110 P.5.063 Effects of nooglutyl on learning and memory in rats with cholinergic deficit Krainev, V.A.
 2005
 15 S2 p. S236-
1 p.
 artikel
111 P.2.001 Effects of olanzapine and verapamilcombination on the neurotransmitter content in Wistar rat brain structures Narkevich, V.B.
 2005
 15 S2 p. S129-
1 p.
 artikel
112 P.4.025 Effects of stress and positive reinforcement on processes of defensive behavior habituation Proshin, A.T.
 2005
 15 S2 p. S186-S187
2 p.
 artikel
113 P.5.035 Effects of thioperamide and raclopride on the striatal extracellular level of dopamine and histamine in Krushinsky-Molodkina and Wistar rats Kudrin, V.S.
 2005
 15 S2 p. S220-S221
2 p.
 artikel
114 P.4.011 Effects of Tyr-MIF-1 family of peptides on antinociception after immobilization stress in rats Bocheva, A.I.
 2005
 15 S2 p. S178-
1 p.
 artikel
115 P.5.108 Efficacy and safety of rivastigmine in patients with mixed dementia Baloescu, A.
 2005
 15 S2 p. S262-
1 p.
 artikel
116 P.2.022 Efficacy of a psychoeducationalprogram for weight gain control in patients taking olanzapine Castrogiovanni, S.
 2005
 15 S2 p. S140-
1 p.
 artikel
117 P.6.039 Efficacy of zuclopentixol treatmentof withdrawal syndrome in opiate dependent patients Khotovitski, A.V.
 2005
 15 S2 p. S286-
1 p.
 artikel
118 P.1.025 Electroencephalographic evaluation ofplacebo and antidepressants action in patients with depression Bochkarev, V.K.
 2005
 15 S2 p. S116-S117
2 p.
 artikel
119 P.5.006 Electrophysiological analysis of the hemantane effects in rats with MPP+-induced parkinsonism Kapitsa, I.G.
 2005
 15 S2 p. S203-
1 p.
 artikel
120 P.3.025 Electrophysiological characteristics ofsingle neuron responses to anxiolytic drugs in different brain structures Sharonova, I.N.
 2005
 15 S2 p. S153-S154
2 p.
 artikel
121 P.5.101 Electrophysiological patterns of brain activation in persons at familial risk for Alzheimer's disease Ponomareva, N.V.
 2005
 15 S2 p. S258-S259
2 p.
 artikel
122 P.4.012 Embryonic serotonin deficiency changes activity of 5-HT3 receptors implicated in prolonged pain mediation in the formalin test in adult rats Butkevich, L.P.
 2005
 15 S2 p. S178-S179
2 p.
 artikel
123 P.3.020 Emotional stress induced dominantlethal mutations in mice which may be prevented by a tranquilizer Daugel-Dauge, N.O.
 2005
 15 S2 p. S151-
1 p.
 artikel
124 P.5.042 Enhancement of the activity of antiepileptic drugs in combination with mexidol Solomatin, Yu.V.
 2005
 15 S2 p. S224-S225
2 p.
 artikel
125 P.1.042 Epidemiological analysis of theprevalence rate of the depressive syndrome among children in Omsk city T.I. Ivanova O.E. Krakhmaleva 2005
 15 S2 p. S126-
1 p.
 artikel
126 P.3.051 Estimation of placebo effect in therapyof generalized anxiety disorder Chakhava, V.O.
 2005
 15 S2 p. S168-
1 p.
 artikel
127 P.6.006 Ethanol and beta-endorphin.Microelectrophoretic study on frontal cortical neurons of the brain Kozhechkin, S.N.
 2005
 15 S2 p. S267-
1 p.
 artikel
128 P.6.051 Evaluation of the influence of organospecific remedies from the peritoneal liquid on ethanol intoxication in laboratory mice Pozdeyev, N.M.
 2005
 15 S2 p. S292-S293
2 p.
 artikel
129 P.6.048 Experience in the use of a neuroleptic with prolonged action for the treatment of heroin addicted patients Demina, M.V.
 2005
 15 S2 p. S291-
1 p.
 artikel
130 P.4.042 Experimental and clinical evaluation ofneurotropic effect of ecdysten Syrov, V.N.
 2005
 15 S2 p. S195-S196
2 p.
 artikel
131 P.5.039 Experimental and clinicalpharmacokinetics of noopept Bojko, S.S.
 2005
 15 S2 p. S222-S223
2 p.
 artikel
132 P.5.091 Experimental estimation of effects oferythropoietin on consequences of spinal injury Odinak, M.M.
 2005
 15 S2 p. S252-S253
2 p.
 artikel
133 P.6.007 Experimental pharmacological evaluation of Sydnocarb effects: Comparisons with methamphetamine Savchenko, N.M.
 2005
 15 S2 p. S267-S268
2 p.
 artikel
134 P.5.001 Experimental study ofstress-conditioned changes in animal behavior caused by sleep deprivation after administration of GABA imidazole derivative Borodkina, L.E.
 2005
 15 S2 p. S200-
1 p.
 artikel
135 P.6.005 Experimental study of the effect ofcorticosteroid derivatives on craving for alcohol and morphine Stanishevskaya, A.V.
 2005
 15 S2 p. S266-S267
2 p.
 artikel
136 P.3.008 Ex vivo investigation of afobazole effect on H3-diazepam binding by synaptoneurosomal membranes of inbred mice and rats Yarkova, M.
 2005
 15 S2 p. S144-S145
2 p.
 artikel
137 P.5.070 GABA-ergic mechanisms of cerebrovascular effects of novel neuroprotective drugs Mirzo, R.S.
 2005
 15 S2 p. S240-
1 p.
 artikel
138 P.5.033 GABA-receptor macromolecular complexes in rat brain under the conditions of passive readaptation after hypokinesia Balyan, L.S.
 2005
 15 S2 p. S219-
1 p.
 artikel
139 P.5.082 Gender differences in the effect ofnootropic medicine, noopept, in the model of early postnatal hypoxia Trofimov, S.S.
 2005
 15 S2 p. S247-
1 p.
 artikel
140 P.4.031 General characteristics of acute phase proteins in fibromyalgia patients Sobieska, M.
 2005
 15 S2 p. S189-
1 p.
 artikel
141 P.3.011 Genetic dependence of CCK-2 antagonistsand agonists psychotropic effects Kolik, L.G.
 2005
 15 S2 p. S146-
1 p.
 artikel
142 P.6.001 Glucocorticoids can play a dual role in the activation of the reinforcing system of the brain: Directly activate the system and modulate the dopaminergic mechanisms of reward Shabanov, P.D.
 2005
 15 S2 p. S264-
1 p.
 artikel
143 P.1.013 5-HT1A receptors modulate behavior and c-fos expression in ovariectomized rats in forced swim test Fedotova, J.O.
 2005
 15 S2 p. S110-
1 p.
 artikel
144 P.1.033 If antiepileptics are mood stabilisers isepilepsy an affective disorder? Djokic, G.
 2005
 15 S2 p. S120-S121
2 p.
 artikel
145 P.1.015 Imipramine-induced rapid ejaculation inrats Belozertseva, I.V.
 2005
 15 S2 p. S111-S112
2 p.
 artikel
146 P.5.092 Impacts of prenatal stress and dexamethasone administration on the structure of neocortex and hippocampus Otellin, V.A.
 2005
 15 S2 p. S253-
1 p.
 artikel
147 P.5.040 Individualizing dosage regimens of antiepileptic drugs: Multiple Model (MM) adaptive control Bondareva, I.B.
 2005
 15 S2 p. S223-S224
2 p.
 artikel
148 P.6.058 Inducible nitric oxide synthase in the locus coeruleus of human opiate addicts Dyuizen, I.V.
 2005
 15 S2 p. S295-S296
2 p.
 artikel
149 P.3.023 Induction of chromosome aberrationsafter emotional stress and its correction by phenazepam in mice Kulakova, A.V.
 2005
 15 S2 p. S152-S153
2 p.
 artikel
150 P.6.064 Influence of alcohol dependence on oxidative metabolism of xenobiotics in humans Semke, V.Ya.
 2005
 15 S2 p. S299-
1 p.
 artikel
151 P.6.061 Influence of alcohol onpharmacokinetics of novel highly efficient anticonvulsant Shushpanova, T.V.
 2005
 15 S2 p. S297-
1 p.
 artikel
152 P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy Ivanova, S.A.
 2005
 15 S2 p. S136-S137
2 p.
 artikel
153 P.5.095 Influence of cholinergic and GABA-ergicdrugs on the recovery cycles of septo-hippocampal and somatosensorial primary evoked responses Molodavkin, G.M.
 2005
 15 S2 p. S255-
1 p.
 artikel
154 P.3.031 Influence of chronical neonatal injectionof arginine-vasopressin and its C-terminal analogue on the postponed behaviour in white rats Voskresenskava, O.G.
 2005
 15 S2 p. S157-
1 p.
 artikel
155 P.4.035 Influence of food-derived opioid peptides on behaviour and learning ability of white rat pups Stovolosov, I.S.
 2005
 15 S2 p. S191-S192
2 p.
 artikel
156 P.3.012 Influence of Ladasten on monoamineslevel in Maudsley reactive and Maudsley non-reactive rats Voronin, M.
 2005
 15 S2 p. S147-
1 p.
 artikel
157 P.5.021 Influence of M- and N-cholinoblockers on principal manifestations of experimental parkinsonism induced by Nivalin and neurotoxine MPTP Losev, N.A.
 2005
 15 S2 p. S211-S212
2 p.
 artikel
158 P.6.062 Influence of maternal alcoholism onultrastructural alterations of cells of human embryonic brain Solonsky, A.V.
 2005
 15 S2 p. S298-
1 p.
 artikel
159 P.3.015 Influence of neurotensin microinjections into dorsal raphe nucleus on passive avoidance performance in rats Shugalev, N.P.
 2005
 15 S2 p. S148-S149
2 p.
 artikel
160 P.4.036 Influence of pinealectomy on the course of pharmacological effect after acute and chronic administration of psychotropic drugs Popov, A.V.
 2005
 15 S2 p. S192-
1 p.
 artikel
161 P.6.049 Influence of sucrose and saccharin onprimary-reinforcing effect of ethanol in DBA/2 mice Tsoy, M.V.
 2005
 15 S2 p. S291-S292
2 p.
 artikel
162 P.3.007 Influence of the ACHT(4–10) analogue Semax on anxiety and analgesia induced by different stressors Vilensky, D.A.
 2005
 15 S2 p. S144-
1 p.
 artikel
163 P.1.003 Influence of the lithium salts on circadianrhythm of the Li+ excretion with urine in conditions of round-the-clock darkness Zamoshchina, T.A.
 2005
 15 S2 p. S104-S105
2 p.
 artikel
164 P.5.099 Influence of the polyamine sitemodulators on NMDA-induced convulsions in mice Efremov, O.M.
 2005
 15 S2 p. S257-
1 p.
 artikel
165 P.4.044 Influence of various psychotropic drugson human retinal functions Ovanesov, K.B.
 2005
 15 S2 p. S197-
1 p.
 artikel
166 P.5.079 Insulin-like growth factor immunoreactivityin rat cerebellum after acute and repeated unilateral brain injury Grbic, G.
 2005
 15 S2 p. S245-
1 p.
 artikel
167 P.3.019 Interstrain differences in neurotransmitters response in BALB/c and C57BI/6 mice after open field stress Lapitskaia, A.S.
 2005
 15 S2 p. S150-S151
2 p.
 artikel
168 P.5.058 Intramuscular injections of heparin improvethe learning process and change the mediator exchange in Wistar rat brain Kondashevskaya, M.V.
 2005
 15 S2 p. S233-S234
2 p.
 artikel
169 P.6.016 In vivo repeated alcohol craving assessment using electronical diary during alcohol withdrawal Lukasiewicz, M.
 2005
 15 S2 p. S273-
1 p.
 artikel
170 P.5.027 Ischemia-induced apoptosis and necrosis in the explant cultures of the rat organ of Corti Andreeva, N.
 2005
 15 S2 p. S215-S216
2 p.
 artikel
171 P.5.107 Ischemized brain protection by modulatorsof GABA-ergic neurotransmission Balasanyan, M.G.
 2005
 15 S2 p. S261-S262
2 p.
 artikel
172 P.3.027 Kinetic analysis of the processelimination after single and different schemes of multiple administration of cinazepam — A novel prodrug possessing psychotropic activity Zhuk, O.V.
 2005
 15 S2 p. S155-
1 p.
 artikel
173 P.1.001 Lithium oxybutirate and circadianrhythms of renal sodium, potassium, lithium and calcium excretion in rats with right suprachiasmatic nucleus lesion Zamoshchina, T.
 2005
 15 S2 p. S103-
1 p.
 artikel
174 P.4.046 Long-term experience of psychotropic drugs application for treatment of comorbid mental disorders in general hospital inpatients Prokudin, V.N.
 2005
 15 S2 p. S197-S198
2 p.
 artikel
175 P.1.009 L-tryptophan modulates behavioralprocesses at disbalance of thyroid hormones Masalova, O.O.
 2005
 15 S2 p. S107-S108
2 p.
 artikel
176 P.4.018 Male aromatase-knockout mice exhibit normal levels of activity, anxiety and “depressive-like” symptomatology Dalla, C.
 2005
 15 S2 p. S182-
1 p.
 artikel
177 P.6.002 Mechanism of CCK-4 analogue activity in morphine-dependent rats Proskuryakova, T.V.
 2005
 15 S2 p. S264-S265
2 p.
 artikel
178 P.1.002 Melatonin and circadian rhythms of Na+,K+, Ca2+ contents in blood, brain and urine of rats during summer solstices Zamoshchina, T.
 2005
 15 S2 p. S103-S104
2 p.
 artikel
179 P.4.026 Melatonin in the treatment of children with sleep disorders Ayyash, H.F.
 2005
 15 S2 p. S187-
1 p.
 artikel
180 P.5.072 Memory restoring and neuroprotective effects of dipeptide noopept in a photochemical stroke model Romanova, G.A.
 2005
 15 S2 p. S241-
1 p.
 artikel
181 P.1.034 Menopausal hysterical depression asa form of pathological development of personality disorder Ianshina, T.
 2005
 15 S2 p. S121-
1 p.
 artikel
182 P.6.015 Metabolic and reinforcing effects of ADH1B-1/1 genotype, and possibilities of siccine acid dietary supplements Ogutsov, P.P.
 2005
 15 S2 p. S272-S273
2 p.
 artikel
183 P.3.057 Mirtazapine and venlafaxine administration in alcohol detoxification: Impact on anxiety and depression symptoms Tzavellas, E.
 2005
 15 S2 p. S171-S172
2 p.
 artikel
184 P.5.083 Multicomponent action of psychotropicdrugs on activated neutrophilic leukocytes Kovalenko, L.P.
 2005
 15 S2 p. S247-S248
2 p.
 artikel
185 P.3.053 Multivariate statistical analysis of healthy volunteers' individual sensitivity to benzodiazepine tranquilizers Nadorov, S.A.
 2005
 15 S2 p. S169-
1 p.
 artikel
186 P.6.034 Naltrexone and craving: Does it work with eating disorders? Campana, M.
 2005
 15 S2 p. S283-
1 p.
 artikel
187 P.5.023 Neurolipids: Fatty acid amides withserotonin and dopamine as antioxidants and neuroprotectors Bobrov, M.Yu.
 2005
 15 S2 p. S212-S213
2 p.
 artikel
188 P.6.050 Neuronal mechanisms of resistance to stress and drug addiction: Role of CRF and ACTH14–10 Borisova, E.V.
 2005
 15 S2 p. S292-
1 p.
 artikel
189 P.3.018 Neuropharmacological effects of heptapeptide Selank on the neurotransmitter content in brain structures of Wistar rats Klodt, P.M.
 2005
 15 S2 p. S150-
1 p.
 artikel
190 P.1.010 Neuropharmacological effects of threehypericum species in an open field test Capasso, A.
 2005
 15 S2 p. S108-
1 p.
 artikel
191 P.3.029 Neuropharmacological properties of 1-aryl-4[(naphtalimido)alkyl]pipe razines Golturenko, A.V.
 2005
 15 S2 p. S156-
1 p.
 artikel
192 P.3.028 Neuropharmacological properties of 1-(phenylpiperazinylbutyl) acids Andronati, S.A.
 2005
 15 S2 p. S155-S156
2 p.
 artikel
193 P.5.073 Neuroprotective activity ofproproten in experimental model of cerebral hemorrhagic stroke Sergeeva, S.A.
 2005
 15 S2 p. S241-S242
2 p.
 artikel
194 P.5.103 Neuroprotective effect of a syntheticpeptide mimetic of neural cell adhesion molecule, P2, in an in vitro model of ischemic damage Voronin, K.Y.
 2005
 15 S2 p. S259-S260
2 p.
 artikel
195 P.5.065 Neuroprotective effect of nooglutylin rats with experimentally produced hemorrhagic and ischemic stroke Garibova, T.L.
 2005
 15 S2 p. S237-
1 p.
 artikel
196 P.5.022 Neuroprotective effect of Phytomix-40 in experimental parkinsonian syndrome Kucheryanu, V.G.
 2005
 15 S2 p. S212-
1 p.
 artikel
197 P.5.066 Neuroprotective properties of the novelnootropic dipeptide noopept (GVS-111) on the model of severe brain ischemia Us, K.S.
 2005
 15 S2 p. S238-
1 p.
 artikel
198 P.5.074 New antiischemic drug composition Lunshina, E.V.
 2005
 15 S2 p. S242-S243
2 p.
 artikel
199 P.1.040 New approach to development of low-dose CNS-active drug Tolstikova, T.G.
 2005
 15 S2 p. S125-
1 p.
 artikel
200 P.6.011 New highly active thebaine analgesics Tolstikova, T.G.
 2005
 15 S2 p. S270-S271
2 p.
 artikel
201 P.4.033 New nonpeptide ASIC's ligands in experiments “in vitro” Piotrovsky, L.B.
 2005
 15 S2 p. S190-S191
2 p.
 artikel
202 P.3.049 New selective anxiolytic afobazole:Profile and efficiency for treatment of different structures of anxiety disorders Syunyakov, S.A.
 2005
 15 S2 p. S167-
1 p.
 artikel
203 P.5.081 Nitric oxide and oxidative stress in the mechanisms of dopaminergic neurotoxicity: Possible neuroprotective approaches Bashkatova, V.
 2005
 15 S2 p. S246-S247
2 p.
 artikel
204 P.6.047 Non-steroidal anti-inflammatory drugsin the treatment of opiate withdrawal syndrome Rusinova, O.I.
 2005
 15 S2 p. S290-S291
2 p.
 artikel
205 P.5.061 Nootropic activity and mechanism of action of the new 4-aminouracyl derivative Myagkova, I.A.
 2005
 15 S2 p. S235-
1 p.
 artikel
206 P.5.003 Nootropic and anxiolytic effects onrepeated functional disruptions of avoidance responses in rats Inozemtsev, A.N.
 2005
 15 S2 p. S201-S202
2 p.
 artikel
207 P.6.019 Normothymics in treatment of alcohol craving: Results of a comparative study Vinnikova, M.A.
 2005
 15 S2 p. S274-S275
2 p.
 artikel
208 P.5.005 Novel antiparkinsonian drug hemantane Valdman, E.A.
 2005
 15 S2 p. S202-S203
2 p.
 artikel
209 P.3.036 Novel anxiolytic Selank: Results of thePhase II clinical trials Neznamov, G.G.
 2005
 15 S2 p. S159-S160
2 p.
 artikel
210 P.5.056 Novel nootropic peptide Semax, anACTH4-10 analogue, enhances effects of d-amphetamine on the extracellular dopamine level in rat striatum and on locomotor activity of C57B/6 mice Erernin, K.O.
 2005
 15 S2 p. S232-
1 p.
 artikel
211 P.5.068 Objective characterization of behavioral disturbance within two months after middle cerebral artery occlusion Petrov, S.V.
 2005
 15 S2 p. S239-
1 p.
 artikel
212 P.5.069 Objective test of motor asymmetryfollowing focal and global cerebral ischemia Lebedev, S.V.
 2005
 15 S2 p. S239-
1 p.
 artikel
213 P.3.052 Obsessive doubts (“Folie du doute”) Volel, B.A.
 2005
 15 S2 p. S168-S169
2 p.
 artikel
214 P.2.011 Obstetric complication and bipolar disorders: A systematic review and meta-analysis of bipolar disorders compared with healthy controls, unipolar disorders and schizophrenia Scott, J.
 2005
 15 S2 p. S133-S134
2 p.
 artikel
215 P.6.014 On combination relapse preventiontreatment in alcoholic dependency Chirko, V.
 2005
 15 S2 p. S272-
1 p.
 artikel
216 P.5.025 On the action of HSP70 preparation onthe central nervous system Andreyeva, L.I.
 2005
 15 S2 p. S214-
1 p.
 artikel
217 P.6.046 On the use of intravenous drop-by-drop infusion of neuroleptics with the purpose to retain heroin-addicted patients in treatment programme Kotov, S.V.
 2005
 15 S2 p. S290-
1 p.
 artikel
218 P.2.004 Open comparative randomized studyefficacy and tolerability of risperidone, olanzapine and quetiaine in acute mania Belenkaya, D.V
 2005
 15 S2 p. S130-
1 p.
 artikel
219 P.6.028 Opiate receptors blockers in the treatment of alcohol dependence Zhirov, I.V.
 2005
 15 S2 p. S279-S280
2 p.
 artikel
220 P.4.006 Optimization of new anxiolytic drug formulations on the basis of pharmacokinetic researches Zherdev, V.P.
 2005
 15 S2 p. S174-S175
2 p.
 artikel
221 P.1.027 Paroxetine in heroin addiction treatment Rokhlina, M.L.
 2005
 15 S2 p. S117-S118
2 p.
 artikel
222 P.1.024 Paroxetine versus amitriptylinein the long-term treatment of recurrent depression (open randomized active control study) Gorodnichev, A.N.
 2005
 15 S2 p. S116-
1 p.
 artikel
223 P.3.038 Peculiarities of action of anxiolyticafobazole in patients from different typological groups Chumakov, D.V.
 2005
 15 S2 p. S160-S161
2 p.
 artikel
224 P.5.034 Peculiarities of seizure responses in F18 generation of Long-Evans hooded rats following inbreeding Volkova, A.N.
 2005
 15 S2 p. S220-
1 p.
 artikel
225 P.5.100 Peptidergic strategy of pharmacologicalcorrection of asthenic disorders Ushakov, I.B.
 2005
 15 S2 p. S258-
1 p.
 artikel
226 P.3.056 Peripheral-type benzodiazepine receptorbinding sites in platelets of patients with panic disorder associated to separation anxiety symptoms Pini, S.
 2005
 15 S2 p. S171-
1 p.
 artikel
227 P.5.007 Perspectives of the use of a new antioxidant mexidol in the treatment of Parkinson's disease Nerobkova, L.N.
 2005
 15 S2 p. S203-S204
2 p.
 artikel
228 P.5.084 Pharmacokinetics and biotransformation of mexidol in C57BL/6 and BALB/C inbred mice Kravtsova, O.Yu.
 2005
 15 S2 p. S248-
1 p.
 artikel
229 P.3.026 Pharmacokinetics of peptide anxiolytic Selank in rat blood and brain after intranasal administration Zolotarev, Yu.A.
 2005
 15 S2 p. S154-
1 p.
 artikel
230 P.3.034 Pharmacological activity of new1,4-benzodiazepine derivatives — Esters of 3-hydroxyphenazepam and high aliphatic acids Kravchenko, I.A.
 2005
 15 S2 p. S158-S159
2 p.
 artikel
231 P.3.014 Pharmacological validation of a newmodel of anxiety in rats and mice — the Suok (“ropewalking”) test: Sensitivity to diazepam and pentylenetetrazole Kalueff, A.V.
 2005
 15 S2 p. S148-
1 p.
 artikel
232 P.3.039 Phase-I investigation of selective anxiolytic afobazole Kolotilinskaya, N.V.
 2005
 15 S2 p. S161-
1 p.
 artikel
233 P.5.067 Phenomenon of delayed neurodegenerationin rats in modelling brain ischemia Lebedev, S.V.
 2005
 15 S2 p. S238-S239
2 p.
 artikel
234 P.6.032 Pica, anxiety and addiction: Mechanismsand therapy Nevidimova, T.
 2005
 15 S2 p. S282-
1 p.
 artikel
235 P.6.043 Pirlindol in the treatment of heroin addicted patients Rusinov, A.V.
 2005
 15 S2 p. S288-
1 p.
 artikel
236 P.4.016 Place of psychopharmacotherapy in complex treatment of patients with bronchial asthma and chronic obstructive pulmonary disease Krasnov, V.N.
 2005
 15 S2 p. S180-S181
2 p.
 artikel
237 P.1.007 Positive influence of new chemical agent fluoglizine on behaviour of male mice with anxiety/depression-like state Kovalenko, I.L.
 2005
 15 S2 p. S106-S107
2 p.
 artikel
238 P.3.054 Possibility of predicting the effects of benzodiazepine tranquilizers Badyshtov, B.A.
 2005
 15 S2 p. S170-
1 p.
 artikel
239 P.3.042 Possible pharmaceuticaladaptation of premedication to out-patient dental treatment Rabinovich, S.A.
 2005
 15 S2 p. S163-
1 p.
 artikel
240 P.3.044 Posttraumatic and psychogenicdisturbances in veterans of modern war Sherman, M.A.
 2005
 15 S2 p. S164-
1 p.
 artikel
241 P.1.008 Potentiation of analgesic andantidepressive effects after intramuscular and oral administration of adrenaline, cholecystokinin and polyvinylpyrrolidone combinations Serdyuk, S.E.
 2005
 15 S2 p. S107-
1 p.
 artikel
242 P.1.021 Predictors of antidepressant tolerabilityin patients with depressive disorders Ahapkin, R.V.
 2005
 15 S2 p. S114-S115
2 p.
 artikel
243 P.4.049 Preliminary findings from ADORE Italy: Untreated attention-deficit/hyperactivity disorder is a significant burden on the patient and family Dell Agnello, G.
 2005
 15 S2 p. S199-S200
2 p.
 artikel
244 P.5.008 Presynaptic interaction betweenrat brain dopaminergic and glutamatergic systems in the mechanism of action of the novel antiparicinsonian drug hemantane Kovalev, G.I.
 2005
 15 S2 p. S204-
1 p.
 artikel
245 P.4.002 Prolactin levels during the treatmentwith atypical antipsychotic agents Gorobets, L.N.
 2005
 15 S2 p. S172-S173
2 p.
 artikel
246 P.1.039 Prospective course of illness andanxiety disorder comorbidity in 83 bipolar I and 44 bipolar II patients followed in a tertiary center Mian, M.S.
 2005
 15 S2 p. S124-
1 p.
 artikel
247 P.4.017 Protection against organophosphates inducedirreversible acetylcholinesterase inhibition by concomitant administration of donepezil and pyridostygmine Kowalczyk, M.
 2005
 15 S2 p. S181-
1 p.
 artikel
248 P.5.109 Psychiatric disorders in adolescents with juvenile myoclonic epilepsy Jovic, N.J.
 2005
 15 S2 p. S262-S263
2 p.
 artikel
249 P.1.037 Psychiatric, psychological and neurological characteristics of patients with chronic low back pain Chakhava, K.O.
 2005
 15 S2 p. S123-
1 p.
 artikel
250 P.5.044 Psychological features of patients withmigraine Mochalov, A.D.
 2005
 15 S2 p. S225-S226
2 p.
 artikel
251 P.4.003 Psychosomatic types at cerebral-asthenic residual-organic genesis at children Benko, L.
 2005
 15 S2 p. S173-
1 p.
 artikel
252 P.5.106 Psychotropic action of taftsin derivateSelank Kozlovskaya, M.M.
 2005
 15 S2 p. S261-
1 p.
 artikel
253 P.1.045 Psychotropic drugs and homeostatic systems: Mechanism of psychoneuroimmunomodulation Semke, V.Ya.
 2005
 15 S2 p. S127-S128
2 p.
 artikel
254 P.5.029 Putative protective role of glutamateantibodies in Alzheimer's disease Davidova, T.V.
 2005
 15 S2 p. S217-
1 p.
 artikel
255 P.6.045 Pyrogenal in the treatment of sleepdisorders in heroin-addicted patients Makarova, N.Ye.
 2005
 15 S2 p. S289-S290
2 p.
 artikel
256 P.6.022 Reception of dopamine and morphine by the peripheral blood lymphocytes of alcoholic patients with different response to pyrotherapy Gamaleya, N.B.
 2005
 15 S2 p. S276-S277
2 p.
 artikel
257 P.1.014 Regional oxidative metabolismas measured by cytochrome c oxidase histochemistry in rats with low or high exploratory activity: Implications for depression Harro, J.
 2005
 15 S2 p. S110-S111
2 p.
 artikel
258 P.5.057 Regulation of neurotrophin level in the brain is a novel property of neuroprotective and nootropic melanocortin peptides Karpenko, C.A.
 2005
 15 S2 p. S233-
1 p.
 artikel
259 P.6.055 Reinforcing properties of neuropeptidesadministered into the extended amygdala of chronically alcoholized rats Lebedev, A.A.
 2005
 15 S2 p. S294-
1 p.
 artikel
260 P.4.005 Relationships between biopharmaceuticaland pharmacokinetic data in the series of 1,4-benzodiazepines Litvin, A.A.
 2005
 15 S2 p. S174-
1 p.
 artikel
261 P.3.004 Repeated aggressive experience and efficacy of anxiolytics Bondar, N.P.
 2005
 15 S2 p. S142-
1 p.
 artikel
262 P.5.009 Reproductive toxicity of hemantane Smolnikova, N.M.
 2005
 15 S2 p. S205-
1 p.
 artikel
263 P.1.022 Resistant depression treatment:rTMS vs ECT Tsukarzi, E.
 2005
 15 S2 p. S115-
1 p.
 artikel
264 P.3.037 Results of clinical study of ladasten, a drug with stimulatory and anxiolytic activity Syunyakov, S.A.
 2005
 15 S2 p. S160-
1 p.
 artikel
265 P.6.026 Risperidone in the treatment of alcoholdependence Borisov, D.V.
 2005
 15 S2 p. S278-S279
2 p.
 artikel
266 P.5.036 Role of lipid peroxidation and metabotropic glutamate receptors during experimental audiogenic seizures Mahkova, L.A.
 2005
 15 S2 p. S221-
1 p.
 artikel
267 P.4.023 Role of main pathways signal transductioninvolved in realization of pharmacological effects of Ladasten in rat brain Salinigareeva, M.Kh.
 2005
 15 S2 p. S185-
1 p.
 artikel
268 P.2.013 Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week, open-label study in stable patients switched from typical and atypical oral antipsychotics Cetin, M.
 2005
 15 S2 p. S134-S135
2 p.
 artikel
269 P.5.004 Search for neuroprotective substancesamong the derivatives of GABA for treating ischemic stroke Tyurenkov, I.N.
 2005
 15 S2 p. S202-
1 p.
 artikel
270 P.6.059 Search for opiate antagonistsin a series of derivatives of 3,7-diazobicyclo[3.3.1 ]nonane Praliyev, K.D.
 2005
 15 S2 p. S296-S297
2 p.
 artikel
271 P.1.043 Searching for 5-HT2- and 5-HT3-receptorantagonists as a potential neuropsychotropic agents Yakovlev, D.S.
 2005
 15 S2 p. S126-S127
2 p.
 artikel
272 P.2.019 Serotonin 2A receptor gene T102C polymorphismand the response to treatment with second-generation antipsychotics in schizophrenia Juhász, A.
 2005
 15 S2 p. S138-
1 p.
 artikel
273 P.4.024 Serotonin transporter gene polymorphism as a possible modifying factor of individual response to stress Alfimova, M.V.
 2005
 15 S2 p. S185-S186
2 p.
 artikel
274 P.1.018 Serum dehydroepiandrosterone sulfate and cortisol levels in patients with different types of depression Kochetkov, Y.A.
 2005
 15 S2 p. S113-
1 p.
 artikel
275 P.5.019 Serum GFAP and DOPAC urinary excretion as markers of the efficacy of embryonic ventral mesencephalon transplantation into rats with hemiparkinsonism Chekhonin, V.P.
 2005
 15 S2 p. S210-S211
2 p.
 artikel
276 P.1.012 Sex and brain regional differences intissue levels of excitatory amino acids in a rat model of depression Anderzhanova, E.
 2005
 15 S2 p. S109-S110
2 p.
 artikel
277 P.4.030 Sex differences in the effects ofultra-low doses of naltrexone on morphine analgesia in rats Shekunova, E.V.
 2005
 15 S2 p. S188-S189
2 p.
 artikel
278 P.1.026 Spectral analysis of EEG changes indepressed patients exposed to TMS Kapiletti, S.
 2005
 15 S2 p. S117-
1 p.
 artikel
279 P.5.010 Stability of a novel antiparkinsoniandrug hemantane in aqueous solutions Grushevskaya, L.N.
 2005
 15 S2 p. S205-
1 p.
 artikel
280 P.6.038 Statistical analysis of double blind placebo controlled clinical trial of heroin addiction treatment by naltrexone and fluoxetine combination Verbitskaya, E.V.
 2005
 15 S2 p. S285-S286
2 p.
 artikel
281 P.5.016 Stress-protective effect of mexidol on different levels of natural altitudes Tilekeyeva, U.M.
 2005
 15 S2 p. S209-
1 p.
 artikel
282 P.4.037 Study of mechanisms of the ACTH(4–10) analogue SEMAX analgesic activity Ivanova, D.M.
 2005
 15 S2 p. S192-S193
2 p.
 artikel
283 P.5.013 Study of neurotropic effects ofSemax analogues depending on their structure Glazova, N.Yu.
 2005
 15 S2 p. S207-
1 p.
 artikel
284 P.5.093 Study of the behavior of white rats with destroyed olfactory epithelium Kydyakova, T.I.
 2005
 15 S2 p. S254-
1 p.
 artikel
285 P.6.052 Study of the sobering effect of remedy Ru21-green Nuzhnyi, V.P.
 2005
 15 S2 p. S293-
1 p.
 artikel
286 P.6.056 Substance P affects alcohol intake bydopamine-dependent mechanism and displays altered reinforcing properties in ethanol-treated rats Nikolaev, S.V.
 2005
 15 S2 p. S294-S295
2 p.
 artikel
287 P.5.045 Succinate-containing drug attenuates cognitive disorders caused by traumatic brain injury in clinical setting Savateeva, T.N.
 2005
 15 S2 p. S226-
1 p.
 artikel
288 P.2.018 Sudden deaths among hospitalized psychiatric patients Benatov, P.
 2005
 15 S2 p. S137-S138
2 p.
 artikel
289 P.5.020 Targeted transport of PEGylatedimmunoliposomes to brain astrocytes Chekhonin, V.P.
 2005
 15 S2 p. S211-
1 p.
 artikel
290 P.5.026 Taurine rescues hippocampalsynaptic plasticity from ammonia-induced impairment Chepkova, A.N.
 2005
 15 S2 p. S214-S215
2 p.
 artikel
291 P.3.016 The activity of amygdala galaninergicsystem in regulation of stress-induced anxiety behavior Lioudyno, V.I.
 2005
 15 S2 p. S149-
1 p.
 artikel
292 P.3.048 The application of pharmacological drugs for the correction of psychoemotional state in extreme conditions Ikhalaynen, A.A.
 2005
 15 S2 p. S166-S167
2 p.
 artikel
293 P.2.012 The −1727 A/T, −50 C/T and (CAA)n repeat GSK-3β gene polymorphisms and resistance to antipsychotics in schizophrenia Bignotti, S.
 2005
 15 S2 p. S134-
1 p.
 artikel
294 P.3.047 The benefits of usingtherapeutic approaches to improve social adaptation of patients with neurotic and somatoform disorders Kulikova, T.Y.
 2005
 15 S2 p. S166-
1 p.
 artikel
295 P.6.008 The biological activity of a novel fragmentof the natural precursor of dermorphin-Arg-dermorphin and its analogues Guzevatikh, L.S.
 2005
 15 S2 p. S268-S269
2 p.
 artikel
296 P.6.029 The clinical characteristics of long-termbenzodiazepine users with neurotic spectrum disorders Yastrebov, D.V
 2005
 15 S2 p. S280-S281
2 p.
 artikel
297 P.5.098 The combined blockade of GluR1 AMPA receptors and α3β4 N-cholinoreceptors inhibits generation of limbic seizures caused by kainate and nicotine Gmiro, V.E.
 2005
 15 S2 p. S256-S257
2 p.
 artikel
298 P.5.087 The content of monoamines and theirmetabolites in the brain structures of mdx mice with progressive muscular dystrophy Pokrovsky, A.A.
 2005
 15 S2 p. S250-
1 p.
 artikel
299 P.6.031 The danger of cocaethylene use in thefield of drug addiction Peppas, E.
 2005
 15 S2 p. S281-S282
2 p.
 artikel
300 P.4.007 The delayed effects of neonatalbuspirone injections on aggressivity in adult males in two mouse lines Markina, N.V.
 2005
 15 S2 p. S175-
1 p.
 artikel
301 P.4.032 The development of polyunsaturated fatty acids with dopamine and serotonin in their structures for platelet activity regulation Vasilieva, T.M.
 2005
 15 S2 p. S190-
1 p.
 artikel
302 P.2.014 The effect of DHEA administrationon extrapyramidal symptoms in schizophrenia: A randomized double blind placebo controlled trial Nachshoni, T.
 2005
 15 S2 p. S135-S136
2 p.
 artikel
303 P.6.057 The effect of HLDF-6 peptide on formationof morphine tolerance and abusing symptoms: Enkephalinase mechanisms Panchenko, L.F.
 2005
 15 S2 p. S295-
1 p.
 artikel
304 P.4.029 The effect of new N-acetyl-L-asparticacid analogue on dopamine release and synthesis in the rat brain Sergeyev, V.S.
 2005
 15 S2 p. S188-
1 p.
 artikel
305 P.3.003 The effect of Selank on the seasonal depressed animal behaviour Semenova, T.P.
 2005
 15 S2 p. S141-S142
2 p.
 artikel
306 P.5.064 The effect of the novel selectiveanxiolytic afobazole in rats with experimentally produced hemorrhagic stroke Galaeva, I.P
 2005
 15 S2 p. S236-S237
2 p.
 artikel
307 P.4.041 The effect of ultra small doses of thyroliberin on structural changes of biological membranes in vitro Zhernovkov, V.E.
 2005
 15 S2 p. S194-S195
2 p.
 artikel
308 P.2.009 The efficacy of laser therapy in pharmacoresistant schizophrenia Saikin, M.A.
 2005
 15 S2 p. S132-S133
2 p.
 artikel
309 P.5.051 The efficacy of nootropics and antihypoxants in correction of posttraumatic disorders of the brain Zarubina, I.P.
 2005
 15 S2 p. S229-
1 p.
 artikel
310 P.5.050 The efficacy of treatment with tanakan (EGb 761) in relation to cognitive impairment in patients with cerebrovascular disease Zakharov, V.V.
 2005
 15 S2 p. S228-S229
2 p.
 artikel
311 P.3.050 The efficiency of the methods of psychoemotional state correction in modelling conditions Tishchenko, A.A.
 2005
 15 S2 p. S167-S168
2 p.
 artikel
312 P.4.027 The hypertensive ISIAH rat strain offers promise in pharmacological research of arterial hypertension and aggressive behavior Markel, A.L.
 2005
 15 S2 p. S187-
1 p.
 artikel
313 P.6.053 The influence of aqueous extracts of Inula sp. on the pharmacodynamic action and pharmacokinetic parameters of ethanol in experimental animals Zabirova, I.G.
 2005
 15 S2 p. S293-S294
2 p.
 artikel
314 P.5.096 The influence of calcium channel blockade on rat picrotoxin-induced hyperkinesis Yakimovski, A.F.
 2005
 15 S2 p. S255-
1 p.
 artikel
315 P.4.040 The influence of food-derived opioid peptide β-casomorphin-7 on mother-dependent albino rat pups behaviour Dubynin, V.A.
 2005
 15 S2 p. S194-
1 p.
 artikel
316 P.3.005 The influence of 5-HT1A receptor agonists ipsapirone and buspirone on anxious-depressive mice: Comparison of acute and chronic treatments Avgustinovich, D.F.
 2005
 15 S2 p. S143-
1 p.
 artikel
317 P.4.038 The influence of hypotonic swellingand hyportonic shrinking on intracellular sodium concentration in rat brain synaptosomes Waseem, T.V.
 2005
 15 S2 p. S193-
1 p.
 artikel
318 P.5.049 The influence of memantine on cognitionin Alzheimer's disease, mixed dementia and dementia with Lewy bodies Yachno, N.N.
 2005
 15 S2 p. S228-
1 p.
 artikel
319 P.6.054 The influence of processed extract ofbroccoli (Brassica oleracea var. italica) seeds on the pharmacodynamics and pharmacokinetic parameters of ethanol in rats Rozhanets, V.V.
 2005
 15 S2 p. S294-
1 p.
 artikel
320 P.1.029 The influence of sertraline andmianserine on some bivalent cations in patients with major depression Nechifor, M.
 2005
 15 S2 p. S118-S119
2 p.
 artikel
321 P.4.047 The influence of the immunotropicpharmacotherapy on life-quality rates and the expression of astheno-vegetal syndrome at the herpetic infection Redkin, Yu.V.
 2005
 15 S2 p. S198-S199
2 p.
 artikel
322 P.3.046 The natural course of obsessive compulsive disorder over four years: Findings from a prospective community study of adolescents and young adults Lieb, R.
 2005
 15 S2 p. S165-
1 p.
 artikel
323 P.5.030 The nitric oxide system in the development of psychoemotional changes in rats under the conditions of hypokinesia Hakobyan, V.P.
 2005
 15 S2 p. S217-S218
2 p.
 artikel
324 P.4.021 Theoretical conformational analysis of antidepressants as a way for evaluation of their efficiency for pain and itch syndrome management in patients with end-stage renal disease under chronic hemodialysis Shestakova, N.N.
 2005
 15 S2 p. S184-
1 p.
 artikel
325 P.5.071 The peculiarities of the action of Vinpocetine, Nimodipine and Cinnarizine on sensitivity of cerebral vessels to carbon dioxide in rats under condition of hypokinesia Baykov, A.V.
 2005
 15 S2 p. S240-S241
2 p.
 artikel
326 P.3.035 The profile of anti-anxiety action of tofisopam in the treatment of generalized anxiety disorder Kokoszka, A.
 2005
 15 S2 p. S159-
1 p.
 artikel
327 P.3.010 The psychopharmacological analysis ofLadasten effects Voronin, M.
 2005
 15 S2 p. S145-S146
2 p.
 artikel
328 P.1.017 The role of clinical, psychologicaland demographic factors in effect of thymoanaleptic treatment of depression disorders Kanaeva, L.S.
 2005
 15 S2 p. S112-
1 p.
 artikel
329 P.3.033 The role of gestational acute stress inthe development of perinatal pathologies Graf, A.V.
 2005
 15 S2 p. S158-
1 p.
 artikel
330 P.5.018 The role of M-cholinergic andGABA-ergic system in the development of the neuroleptics-induced extrapyramidal disturbances Dagaev, S.G.
 2005
 15 S2 p. S210-
1 p.
 artikel
331 P.5.015 The role of pineal gland peptides in regulationof free radical processes in aging Kozina, L.S.
 2005
 15 S2 p. S208-S209
2 p.
 artikel
332 P.4.004 The sense of coherence, quality of life and symptoms of anxiety and depression in patients with cataract Hyper-Ochalik, M.
 2005
 15 S2 p. S173-S174
2 p.
 artikel
333 P.2.010 The shift of alpha rhythm of EEG in patients with schizophrenia during long-term treatment by atypical antipsychotics Soulimov, G.
 2005
 15 S2 p. S133-
1 p.
 artikel
334 P.6.017 The study of mirtazapine efficacy in the treatment of alcohol dependence Agibalova, T.V.
 2005
 15 S2 p. S273-S274
2 p.
 artikel
335 P.5.104 The study of protective properties ofL-phenylalanine on the model of stroke (hippocampal slice culture exposed to oxygen-glucose deprivation) Malyarevskyy, P.Y.
 2005
 15 S2 p. S260-
1 p.
 artikel
336 P.6.044 The treatment of algesic disorders inopiate-addicted patients by the use of endogenous peptides Altshuler, V.B.
 2005
 15 S2 p. S289-
1 p.
 artikel
337 P.1.036 The treatment of organic affective disorders in liquidators of the accident at Chernobyl Atomic Station using the indices of quality of life (QoL) and social functioning Redkin, Y.V.
 2005
 15 S2 p. S122-S123
2 p.
 artikel
338 P.6.018 The use of balanced aminoacid“Aminosol KE” for treatment of post-withdrawal disorders in chronic alcoholism patients Utkin, S.Y.
 2005
 15 S2 p. S274-
1 p.
 artikel
339 P.1.038 The use of lidevine in complex treatment of heroin patients abusing alcoholic beverages Doudko, T.N.
 2005
 15 S2 p. S123-S124
2 p.
 artikel
340 P.4.028 Toxic influence of the new adenine derivative VMA-98-17 on neurologic status of rats Myagkova, I.A.
 2005
 15 S2 p. S188-
1 p.
 artikel
341 P.5.088 Toxicity of excitatory amino acids in organotypic retinal cultures of postnatal and adult rats Victorov, I.
 2005
 15 S2 p. S250-S251
2 p.
 artikel
342 P.1.046 Transcranial magnetic stimulation in combination with antidepressant drugs in major depression: Preliminary results Rossini, D.
 2005
 15 S2 p. S128-S129
2 p.
 artikel
343 P.5.024 Transport of proserine through blood-brain barrier using poly(butylcyanoacrylate) nanoparticles coated with polysorbate-80 in rats Abdel Wahab, B.A.
 2005
 15 S2 p. S213-S214
2 p.
 artikel
344 P.1.032 Treatment of bulimia nervosa with fluvoxamine: A randomized controlled trail Siano, C.
 2005
 15 S2 p. S120-
1 p.
 artikel
345 P.6.040 Treatment of craving for drugs withrisperidone in patients with heroin addiction Mokhnatchev, S.O.
 2005
 15 S2 p. S287-
1 p.
 artikel
346 P.2.020 Treatment with risperidone in earlyonset of psychotic decompensations in adolescents Graovac, M.
 2005
 15 S2 p. S138-S139
2 p.
 artikel
347 P.1.019 Typology of seasonal depressions Medvedev, V.E.
 2005
 15 S2 p. S113-S114
2 p.
 artikel
348 P.3.045 Unlicensed and off-label sedatives prescription in the cardiology and cardiosurgery pediatric care units Panovic-Bajcetic, M.
 2005
 15 S2 p. S165-
1 p.
 artikel
349 P.2.017 Use of actovegin in complex care ofresidual-organic psychosyndrome in children Malinina, E.
 2005
 15 S2 p. S137-
1 p.
 artikel
350 P.4.001 Use of DNA/Protein Array for profiling transcription factors activated by aminoadamantane compound Ladasten in rat brain Vakhitova, I.V.
 2005
 15 S2 p. S172-
1 p.
 artikel
351 P.3.043 Use of proproten for premedication ofpatients in the dental practice Larentsova, L.I.
 2005
 15 S2 p. S163-S164
2 p.
 artikel
352 P.1.031 Use of sibutramine, an inhibitor of thereuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study Casella, A.
 2005
 15 S2 p. S119-S120
2 p.
 artikel
353 P.6.020 Use of the neurometabolic drug “Semax” for complex treatment of alcohol delirium Strelets, N.V.
 2005
 15 S2 p. S275-
1 p.
 artikel
354 S.4.3 Aging and brain degeneration Nilsson, L.-G.
 2005
 15 S2 p. S101-
1 p.
 artikel
355 S.1.1 Animal modeling of depressive disorders Leonard, B.E.
 2005
 15 S2 p. S89-S91
3 p.
 artikel
356 S.3.3 Behavioral mechanisms of nicotine abuse: Search for novel pharmacotherapies to treat nicotine dependence Bespalov, A.Y.
 2005
 15 S2 p. S98-
1 p.
 artikel
357 S.1.2 Cellular plasticity in response to antidepressant treatment Tingström, A.
 2005
 15 S2 p. S91-S92
2 p.
 artikel
358 S.1.4 Comorbidity of depression and anxiety Kaspe, S.
 2005
 15 S2 p. S93-
1 p.
 artikel
359 S.4.4 Complex relationships exist betweenAlzheimer's disease (AD) and depression Robert, P.H.
 2005
 15 S2 p. S101-S102
2 p.
 artikel
360 S.1.3 Depressive episodes: Nosology andtherapy Smulevich, A.B.
 2005
 15 S2 p. S92-
1 p.
 artikel
361 S.3.2 Endorphins and addiction van Ree, J.M.
 2005
 15 S2 p. S97-S98
2 p.
 artikel
362 S.2.2 Experimental models of anxiety Voronina, T.A.
 2005
 15 S2 p. S94-
1 p.
 artikel
363 S.2.5 Is there still a place for benzodiazepines? Pini, S.
 2005
 15 S2 p. S95-S96
2 p.
 artikel
364 S.4.2 Neurodegenerative diseases and oxidative stress Emerit, J.
 2005
 15 S2 p. S100-S101
2 p.
 artikel
365 S.4.5 New approaches to Alzheimer's diseasetherapy: Role of neurotrophic stimulation Gavrilova, S.I.
 2005
 15 S2 p. S102-
1 p.
 artikel
366 S.3.4 New approaches to treatment of pathologicalcraving for psychoactive substances Ivanets, N.N.
 2005
 15 S2 p. S99-
1 p.
 artikel
367 S.3.1 Polymorphism of dopamine system genesand predisposition to alcoholism and drug addiction Anokhina, L.P.
 2005
 15 S2 p. S97-
1 p.
 artikel
368 S.2.3 Stress related disorders: Approach todiagnosis and treatment Krasnov, V.N.
 2005
 15 S2 p. S94-S95
2 p.
 artikel
369 S.2.1 Translation of animal models to humanpsychopathology Groenink, L.
 2005
 15 S2 p. S93-S94
2 p.
 artikel
370 S.3.5 Treatment of addiction Lesch, O.M.
 2005
 15 S2 p. S99-
1 p.
 artikel
371 S.2.6 Treatment of anxiety disorders Bandelow, B.
 2005
 15 S2 p. S96-
1 p.
 artikel
372 S.2.4 Underlying pathology and treatment of social phobia Zohar, J.
 2005
 15 S2 p. S95-
1 p.
 artikel
373 S.4.1. Vasopressin and neurotensine moleculesand the aging brain Ostrovskaya, R.U.
 2005
 15 S2 p. S100-
1 p.
 artikel
                             373 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland